000			01567 a2200409 4500
005			20250514211817.0
264		0	_c20050315
008			200503s 0 0 eng d
022			_a0893-8652
024	7		_a10.3122/jabfm.17.6.401 _2doi
040			_aNLM _beng _cNLM
100	1		_aShrank, William H
245	0	0	_aA bitter pill: formulary variability and the challenge to prescribing physicians. _h[electronic resource]
260			_bThe Journal of the American Board of Family Practice _c
300			_a401-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xeconomics
650	0	4	_aCalcium Channel Blockers _xeconomics
650	0	4	_aCalifornia
650	0	4	_aCost Sharing
650	0	4	_aDrug Costs
650	0	4	_aDrug Utilization Review
650	0	4	_aFormularies as Topic
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xeconomics
650	0	4	_aManaged Care Programs _xeconomics
650	0	4	_aPharmaceutical Services _xeconomics
650	0	4	_aPrescription Fees
650	0	4	_aProton Pump Inhibitors
650	0	4	_aProton Pumps _xeconomics
650	0	4	_aRetrospective Studies
700	1		_aEttner, Susan L
700	1		_aGlassman, Peter
700	1		_aAsch, Steven M
773	0		_tThe Journal of the American Board of Family Practice _gvol. 17 _gno. 6 _gp. 401-7
856	4	0	_uhttps://doi.org/10.3122/jabfm.17.6.401 _zAvailable from publisher's website
999			_c15260210 _d15260210